Sign in to fuzzto save your conversations, follow your research and come back anytime.

Clean Science and Technology Limited is an Indian specialty chemical manufacturing company founded in 2003. It produces various chemicals including MEHQ, Guaiacol, and 4MAP at its plant in Kurkumbh MIDC, Pune. The company focuses on developing eco-friendly and cost-competitive technologies using in-house catalytic processes. It operates three zero liquid discharge production facilities in Maharashtra, each with its own R&D unit. The company's products are categorized into FMCG chemicals, performance chemicals, and pharmaceutical chemicals. In 2021, Clean Science and Technology went public through an IPO. The company has four wholly-owned subsidiaries and has recently expanded its product line and manufacturing capacity, including the addition of a 5 MW solar power plant in 2023.
In the news

Trading Ideas: Clean Science, Urban Company, RBL Bank & Others

Clean Science & Technology Q3 profit up 27% QoQ to ₹58.27 crore

LIC Stock Shows Favorable Risk-Reward Despite Competitive Pressures

Clean Science & Technology Q4 profit drops 21.35% to ₹58.27 cr

Amansa Holdings acquires 1.1% stake in Clean Science

Clean Science Q3 profit drops 30% to ₹45.8 cr, declares ₹2 dividend
Company insights, generated from the most recent coverage.
Secured 5-year supply deal with Kemin Industries and collaboration with Geneus Chem AG for HALS products — enhances long-term revenue visibility and entry into high-value segments.
Q1 FY27 EBITDA margin hit record high of >46% despite 4.3% YoY revenue decline — demonstrates strong operational efficiency and pricing power.
Management expects growth pickup from Q3/Q4 FY27, citing extended client decision cycles due to global trade uncertainty as current headwind.
The Quarter story
The two most recent quarterly results, compared side-by-side.
Clean Science & Technology rebounds in Q1 FY27 with higher sales and profits, though rising input and operating costs require close monitoring.
Consolidated total revenue grows from ₹243 Cr to ₹268 Cr from Q1 FY26 to Q1 FY27, showing steady demand recovery
Consolidated raw material expenses rise from ₹84 Cr to ₹105 Cr from Q1 FY26 to Q1 FY27, squeezing production margins
Consolidated profit after tax rebounds from ₹46 Cr to ₹73 Cr from Q3 FY26 to Q1 FY27, restoring bottom-line strength
Consolidated other operating expenses increase from ₹59 Cr to ₹67 Cr from Q1 FY26 to Q1 FY27, adding to cost pressure
Finance costs remain at ₹0 from Q1 FY26 to Q1 FY27, confirming a completely debt-free balance sheet
Consolidated raw material cost share jumps from 35.0% to 39.7% from Q1 FY26 to Q1 FY27, reflecting higher input prices
Performance chemicals revenue share expands from 74% to 81% from Q1 FY26 to Q1 FY27, becoming the clear growth engine
Consolidated EBITDA margin slips from 41.7% to 36.5% from Q1 FY26 to Q1 FY27, despite the sales recovery
Standalone PAT margin climbs from 28.9% to 36.0% from Q3 FY26 to Q1 FY27, highlighting improved cost efficiency
Standalone EBITDA margin eases from 45.6% to 42.7% from Q4 FY26 to Q1 FY27, signaling ongoing pricing challenges